# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-07T08:21:28.127644
**Route:** OpenRouter + LaTeX
**Tokens:** 22933 in / 1818 out
**Response SHA256:** 4c41f6fffb886b80

---

No fatal errors detected.

I checked the manuscript thoroughly for the four categories you requested (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). Summary of checks and findings:

1) Data-Design Alignment
- Treatment timing vs. data coverage: Treatment cohorts are defined 2017–2022 and the analysis uses ACS 5-year estimates (2017–2022) for treatment assignment; the text and tables consistently restrict treatment assignment to 2017–2022 while transcript/outcome data are available through 2023 but the analysis panel is 2017–2022. Max(treatment year)=2022 ≤ max(data year for outcomes in analysis)=2022 — consistent.
- Post-treatment observations: Staggered DiD uses cohorts 2017–2022. Cohorts treated earlier (2017–2020) have post-treatment observations; later cohorts (2021, 2022) have more limited post periods but are small cohorts and the paper notes cohort sizes and treats them accordingly. The paper explicitly allows one year anticipation because of ACS 5-year smoothing. I saw no claim that relies on impossible post-treatment observation (e.g., claiming multi-year post-treatment effects for a cohort with zero post-treatment years).
- Treatment definition consistency: The treatment definition ("first year 5-year ACS broadband > 70%") is used consistently across the main text, figures, and tables (Tables and Figures that describe cohorts and treatment timing match the treatment variable definition).

2) Regression Sanity
- Standard errors and coefficients: Reported coefficient magnitudes and standard errors across Tables (main DID, individual foundations, robustness, equivalence tables) are in plausible ranges for the outcomes (words per 1,000; indices). No SEs > 1000, no SE > 100 × |coef|, no impossibly large coefficients for log or index outcomes, no negative SDs, no R² outside [0,1] reporting errors, and no "Inf"/"NaN" entries in reported regression outputs.
- Cluster counts: State-level clustering uses 47 clusters; that is reported and plausible.
- TWFE and C-S comparisons: Both estimators reported and appear comparable; no obvious numerical artifacts.

3) Completeness
- No placeholder tokens ("TBD", "TODO", "XXX") found in the main tables/figures/tables of results.
- Regression tables include standard errors and sample counts (places and place-years). Summary statistics tables include Ns. Figures are referred to and present (paths/filenames present in LaTeX; captions and labels consistent).
- Robustness and sensitivity analyses are reported (MDE, TOST, HonestDiD, clustering sensitivity).
- Replication info and data/code availability are provided.

4) Internal Consistency
- Numbers match across text and tables for the key reported figures (e.g., aggregate ATT and its SE and CI are consistent in text and Table~\ref{tab:main_did} / figures).
- Treatment cohort composition (Table) and the description in text are consistent.
- Sample sizes and place/place-year totals are consistent across tables (Total places = 530, place-years = 2,751).
- The treatment rate (≈98%) and the implications for power and feasibility of subgroup analysis are consistently discussed and reflected in the heterogeneity section.
- The one-year anticipation handling for ACS 5-year smoothing is consistently described and applied.

Minor notes (non-fatal; not requested to fix but worth being aware of)
- The robustness row for the Sun-Abraham estimator reports a point estimate but notes that a standard error is "unavailable from IW estimator." This is a limitation of reporting that estimator's aggregated point estimate without a comparable SE; it is not a fatal error but you may want to (a) clarify why no SE is reported (methodological limitation) or (b) present cohort-level Sun & Abraham standard errors or bootstrap CIs if feasible. This is not a blocker for submission but improve clarity.
- Some subgroup heterogeneity cells show "estimation failed" / "infeasible" due to lack of controls — the paper documents this clearly; that is not a fatal error but an inherent limitation of the data which the authors correctly note and interpret.
- The paper is transparent about power limitations; ensure that any journal reviewers who focus on power will see the detailed MDE and TOST results already provided.

Final recommendation per your instructions:

ADVISOR VERDICT: PASS